These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 3693872)
21. [A special flicker fusion frequency method for detection of the effects of gerontopharmaceuticals exemplified by the L-eburnamonine study]. Plörer S; Gerstenbrand F; Lehmann HE; Saltuari L; Stralkowski E Psychiatr Neurol Med Psychol (Leipz); 1985 Nov; 37(11):635-42. PubMed ID: 4089045 [TBL] [Abstract][Full Text] [Related]
22. [Clinical and Neuropsychological changes associated with vincamin treatment in cerebrovascular disease (author's transl)]. Ambrozi L; Bruck J; Tschabitscher H Nervenarzt; 1982 Mar; 53(3):141-3. PubMed ID: 7078689 [No Abstract] [Full Text] [Related]
23. The abuse of a sleeping pill that contains the active substance flunitrazepam (FZ)--for example, Rohypnol--and the effects of FZ intoxication, such as enhanced violence and disturbed memory. Dåderman AM; Fredriksson B; Nilsson LH; Kristiansson M; Lidberg L J Am Acad Psychiatry Law; 2004; 32(4):467-8. PubMed ID: 15704634 [No Abstract] [Full Text] [Related]
24. Amnesic action of and skills related to driving after intravenous flunitrazepam. Korttila K; Linnoila M Acta Anaesthesiol Scand; 1976; 20(2):160-8. PubMed ID: 7093 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes. Hindmarch I; Fuchs HH; Erzigkeit H Int Clin Psychopharmacol; 1991; 6(1):31-43. PubMed ID: 2071888 [TBL] [Abstract][Full Text] [Related]
26. [Treatment of cerebrovascular insufficiency. A double blind trial of Cetal retard against cinnarizine (author's transl)]. Bartels H MMW Munch Med Wochenschr; 1977 Oct; 119(43):1407-10. PubMed ID: 412079 [TBL] [Abstract][Full Text] [Related]
27. Neuroprotective effects of novel nanosystems simultaneously loaded with vinpocetine and piracetam after intranasal administration. Nasr M; Wahdan SA Life Sci; 2019 Jun; 226():117-129. PubMed ID: 30981765 [TBL] [Abstract][Full Text] [Related]
28. The effects of acute and repeated doses of suriclone on subjective sleep, psychomotor performance and cognitive function in young and elderly volunteers. Gilburt SJ; Fairweather DB; Kerr JS; Hindmarch I Fundam Clin Pharmacol; 1992; 6(6):251-8. PubMed ID: 1362556 [TBL] [Abstract][Full Text] [Related]
29. Vinpocetine restores cognitive and motor functions in Traumatic brain injury challenged rats. Bagri K; Deshmukh R Inflammopharmacology; 2022 Dec; 30(6):2243-2259. PubMed ID: 36190686 [TBL] [Abstract][Full Text] [Related]
30. [The use of vinpocetine in chronic disorders caused by cerebral hypoperfusion]. Horváth S Orv Hetil; 2001 Feb; 142(8):383-9. PubMed ID: 11263076 [TBL] [Abstract][Full Text] [Related]
32. Amnesic effects and subjective ratings during repeated dosing of flunitrazepam to healthy volunteers. Ingum J; Beylich KM; Mørland J Eur J Clin Pharmacol; 1993; 45(3):235-40. PubMed ID: 8276047 [TBL] [Abstract][Full Text] [Related]
33. Drug-alcohol interactions on psychomotor skills: zopiclone and flunitrazepam. Seppälä T; Nuotto E; Dreyfus JF Int Pharmacopsychiatry; 1982; 17 Suppl 2():127-35. PubMed ID: 7188370 [TBL] [Abstract][Full Text] [Related]
34. Protective effect of vinpocetine against brain damage caused by ischemia. Rischke R; Krieglstein J Jpn J Pharmacol; 1991 Jul; 56(3):349-56. PubMed ID: 1895579 [TBL] [Abstract][Full Text] [Related]
35. The psychopharmacological effects of Ginkgo biloba extract in normal healthy volunteers. Subhan Z; Hindmarch I Int J Clin Pharmacol Res; 1984; 4(2):89-93. PubMed ID: 6469442 [TBL] [Abstract][Full Text] [Related]
36. [Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke]. Dézsi L; Kis-Varga I; Nagy J; Komlódi Z; Kárpáti E Acta Pharm Hung; 2002; 72(2):84-91. PubMed ID: 12498034 [TBL] [Abstract][Full Text] [Related]
37. Vinpocetine improved neuropsychiatric and epileptic outcomes in a patient with a GABRA1 loss-of-function variant. Gjerulfsen CE; Mieszczanek TS; Johannesen KM; Liao VWY; Chebib M; Nørby HAJ; Gardella E; Rubboli G; Ahring P; Møller RS Ann Clin Transl Neurol; 2023 Aug; 10(8):1493-1498. PubMed ID: 37434477 [TBL] [Abstract][Full Text] [Related]
38. Prevention of drug-induced memory impairment by immunopharmacotherapy. Treweek JB; Sun C; Mayorov AV; Qi L; Levy CL; Roberts AJ; Dickerson TJ; Janda KD J Med Chem; 2008 Nov; 51(21):6866-75. PubMed ID: 18921991 [TBL] [Abstract][Full Text] [Related]
39. Vinpocetine prevents haloperidol-induced cognitive and working memory deficits through attenuation of oxidative and nitrosative stress in mice. Ishola IO; Isaac AI; Adeyemi OO Niger J Physiol Sci; 2020 Dec; 35(2):203-208. PubMed ID: 34009202 [TBL] [Abstract][Full Text] [Related]
40. Vinpocetine inhibits breast cancer cells growth in vitro and in vivo. Huang EW; Xue SJ; Zhang Z; Zhou JG; Guan YY; Tang YB Apoptosis; 2012 Oct; 17(10):1120-30. PubMed ID: 22729609 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]